Digisonics And Medis Partner To Provide Comprehensive Pediatric And Adult Cardiovascular MR Image Review, Analysis And Structured Reporting Solution

Houston, TX -- Digisonics and Medis Partner to Provide Comprehensive Pediatric and Adult Cardiovascular MR Image Review, Analysis and Structured Reporting Solution

Digisonics and Medis are proud to announce a partnership to provide a comprehensive single system solution for image analysis and structured reporting of pediatric and adult CV MR studies. The integrated system solution between Digisonics and Medis will result in a seamless, efficient MR workflow.

Users will have access to fast image review and analysis of their MR studies via the Medis QMass® ES advanced quantitation software which provides built-in disease-oriented review layouts and cross referencing tools. Users can analyze cardiovascular dimensions and morphology, myocardial function (MR & CT), phase-contrast blood flow, tissue characterization1 (late enhancement, T2 weighted edema, T2/T2* mapping, T1 mapping), myocardial perfusion1 and MR angiography. Results from the analysis completed in Medis will be saved directly back into the Digisonics cardiovascular information system.

With the completed image analysis from Medis, clinicians can then quickly summarize their findings in a structured report using Digisonics’ easy-to-navigate picklists and summary macros. These concise (usually one-page) and highly-configurable reports also offer the ability to embed post-processed study images and graphics such as charts or clinical diagrams.

“Digisonics is excited to partner with Medis in offering the most comprehensive combination of Cardiac MR imaging and reporting functionality on the market,” said Steve Dissing, Director of Sales and Marketing at Digisonics. “Combining Digisonics’ 39 years of experience in structured reporting with the MR imaging toolset from Medis will provide clinicians and researchers the comprehensive analysis, reporting and data mining capabilities they require.”

“This solution combines Digisonics’ outstanding reporting and data mining capabilities with our long-term available gold standard quantitative analysis and post processing tools providing a comprehensive and efficient solution for both clinicians and researchers,” said Daniel Garcia Miranda, VP Corporate Marketing & Sales at Medis.

QMass is a registered trademark of Medis medical imaging systems bv in the United States and in other countries. QMass is cleared for market in the US.

1 The use of contrast agent for cardiovascular MR procedures is not FDA-approved, therefore, the myocardial perfusion and tissue characterization modules of QMass have not received US 510(k) market clearance.

Myocardial perfusion and tissue characterization modules are available on demand in the US for research purpose only.

Help employers find you! Check out all the jobs and post your resume.